Pricing Log in Create free account
Saturday 17 October 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

VRTX Healthcare Biotechnology

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.

499.39 9.36 −1.84%
Market cap
$129.0B
P/E
28.8×
Fwd P/E
25.5×
Dividend yield
—
F-score
8/9
Altman Z
12.06
Beneish M
−2.17
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Vertex Pharmaceuticals Incorporated (VRTX) Current ratio

Alert me on Current ratio

Vertex Pharmaceuticals Incorporated's current ratio at the end of the quarter to 30 June 2026 was 3.2×, up 0.3× from fiscal 2025 (2.9×). Over the past ten years it has ranged from 2.3× (fiscal 2016) to 4.8× (fiscal 2022); the current reading is higher than 36% of that period. That is below the Biotechnology industry median of 4.7× and above the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.9× 7.76%
FY2024 2.7× (32.48%)
FY2023 4.0× (17.39%)
FY2022 4.8× 8.14%
FY2021 4.5× 3.03%
FY2020 4.3× 19.90%
FY2019 3.6× 5.32%
FY2018 3.4× 4.54%
FY2017 3.3× 41.99%
FY2016 2.3× (16.87%)

Quarterly newest first

Period Current ratio Change
Jun 2026 3.2× 5.38%
Mar 2026 3.0× 4.20%
Dec 2025 2.9× 22.83%
Sep 2025 2.4× (6.27%)
42 more quarters

Against its own ten years

Low 2.3× High 4.8×
Ten-year median 3.4×
Current reading's percentile 36

Current ratio against peers

Company Current ratio
ROIV Roivant Sciences Ltd. compare 16.7×
RVMD Revolution Medicines, Inc. compare 11.4×
ARGX argenex SE compare 5.1×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 3.4×
REGN Regeneron Pharmaceuticals, Inc. compare 3.3×
VRTX Vertex Pharmaceuticals Incorporated 3.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.1×
RPRX Royalty Pharma PLC compare 2.8×
MRNA Moderna, Inc. compare 2.3×
Biotechnology industry median 4.7×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on VRTX